Background: The incidence of inflammatory bowel disease (IBD) varies widely between different countries. This large variation is also observed for the incidence of its main two forms, ulcerative colitis (UC) and Crohn's disease (CD). Controversy exists whether IBD incidence is increasing, especially in western countries. Currently no data are available for Austria. This study therefore aimed to evaluate for the first time the incidence of IBD over an eleven-year period in Styria, a province of Austria with a population of 1.2 million. Methods: All patients with an initial diagnosis of IBD between 1997 and 2007, who were Styrian residents, were eligible for this retrospective study. Data were acquired from electronically stored hospital discharge reports and individual reports by patients and physicians. According to population density Styria was divided into two rural and one urban area. Results: Throughout the study period 1527 patients with an initial diagnosis of IBD were identified. The average annual incidence was 6.7 (95% CI 6.2-7.1) per 100,000 persons per year for CD and 4.8 (95% CI 4.5-5.2) for UC. The average annual incidence increased significantly (p b 0.01) for both diseases during the 11 year study period. Median age at initial diagnosis was 29 years (range 3-87) for CD and 39 years (range 3-94) for UC. At diagnosis, 8.5% of all IBD patients were b 18 years of age. The incidence of both CD and UC was significantly higher in the urban area than in rural areas (CD: 8.8, 95% CI 7.8-9.8 versus 5.5, 95% CI 4.7-6.4 and 5.9, 95% CI 5. We observed an overall increase in the incidence of ulcerative colitis and Crohn's disease in a part of Austria during an eleven year period. IBD was more predominant in the largest urban area than in rural areas.
Introduction
During the last 50 years inflammatory bowel disease (IBD) with its major forms, ulcerative colitis (UC) and Crohn's disease (CD) raised to one of the major challenges in gastroenterology. In spite of the multitude of studies available it remains unclear whether IBD has definitely become more frequent in Europe within the last 15-20 years or if merely diagnostic accuracy has improved. Moreover, the change of incidence rates is not uniform but rather varies depending on time and location of studies performed and disease assessed. In the 1950s Evans already found in a carefully performed study a crude incidence of 6.5 for UC in the Oxford area. 1 This incidence is similar to more recent results from numerous European studies (Table 1 ). In contrast, the development in the incidence of CD differs widely. While the incidence has remained stable since the 1970s in the United States 2 and in Western Europe 3-5 a sharp increase in incidence of CD was noted in several eastern European countries such as Hungary and Croatia. 6, 7 In Austria no data exist on the incidence of IBD at all. Styria, a province in the southeast of Austria, is particularly well defined with respect to geography and administration. It has a dominant public health care provider (KAGES) and a low migration rate. Its capital, the city of Graz, has a catchment area representing an urban and highly industrialized region and is in sharp contrast to the sparsely populated rural parts of the province. The primary aim of this study was to determine the incidence of IBD and its development over an eleven year period in this province of Austria considering all age groups. Furthermore, we aimed to elucidate differences in incidence between rural versus the largest urban area.
Methods

Study area
Styria is the second largest province of Austria ( Fig. 1A ) with a population of 1.2 million. It is divided into 3 areas (Fig. 1B) . The northern part, named "Upper Styria", is an alpine region characterized by a rough climate and a population density averaging merely 52 inhabitants/km 2 .
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The southern part, called "Lower Styria", is distinguished by a mild, almost Mediterranean climate and hilly landscape. Its population density amounts to 83/km 2 . 8 The third part comprises Graz, the capital of Styria and its surrounding suburbs called "Graz-surroundings". It is a mainly urban and highly industrialized area with a high population density of 946 inhabitants/km 2 . 8 For data analysis, we therefore divided Syria into two rural and one urban area.
Study population
In Styria a census is performed every 10 years and in 2002 a central population registry was installed. These data are collected by the Austrian Federal Institute of Statistics. During the investigation period from 1997 to 2007 the population grew from 1,184,587 to 1,202,483. Migration rate was relatively constant, with an average immigration of 4000 persons/year. Inter-regional migration in Styria was much higher. In 2008 88,000 inhabitants changed their domicile; the trend is that people abandon their rural domiciles in upper Styria and move to new urban residences in the neighborhood of Graz. 
Acquisition of data
Nearly 80% of all hospitals in Styria are public facilities and managed by the governmental holding company "KAGES". In addition, there are 5 private hospitals owned and managed by different religious organizations. All hospitals participated. To optimize acquisition of data, we used three different approaches.
First: search for ICD 9 and 10 codes
The search was performed in all Styrian hospitals (public and private). Table 2 summarizes the ICD 9/10 codes sought for IBD. We were searching for patients with at least one matching ICD code present in ICD 9 or ICD 10. By this approach a total of 23,274 cases were found (Fig. 2) . The hospital discharge records and/or other reports were then subjected to case review and further selected according to concurrence with our diagnostic criteria (detailed below) and date of initial diagnosis. In the study period from Jan. 1, 1997 to Dec. 31, 2007 a total of 1458 patients with an accepted initial diagnosis of IBD were identified. Another 1157 patients with the diagnosis of IBD had been found through data review but were excluded as diagnosis had been established before or after the investigated time period.
Second: information of physicians
The study was announced and introduced to all general practitioners, internists, surgeons and pediatricians in Styria, explaining motives for this study and the aims we wanted to achieve. Patients could be registered by phone or internet. The requested master data comprised name, gender, 
Third: repeated appeals for voluntary reporting
There were repeated appeals for voluntary reporting through the patient self-help group "ÖMCCV" (Austrian Association for Crohn's Disease and Ulcerative Colitis). The study was also announced and advertised in doctor's offices and hospitals, by a press release in 3 popular local Styrian newspapers and by a report in the local Styrian broadcasting system.
A total of 69 patients who fulfilled our inclusion criteria were recruited without the use of ICD codes (Fig. 2) .
A major fraction of patients (954/1527; 62%) were seenat least for one time in the IBD outpatient clinic in Graz for second opinion or further management. In 704 (46%) patients diagnosis of IBD was made in other hospitals. The 69 (4%) patients who were identified by voluntary reporting did not present to any hospital in Styria for evaluation or treatment of intestinal problems.
Data management
Data were entered and stored using computer software specifically designed for scientific use of medical information (ArchiMed). 10 The occasional occurrence of multiple reports from identical subjects was identified and corrected. Data collection closed on March 31, 2010.
Case ascertainment and criteria for admission into study
Mandatory for inclusion in this retrospective study was an accepted initial diagnosis of IBD between January 1, 1997 and December 31, 2007. January 1, 1997 was chosen because administrative software was available from this time point onwards for all hospitals, including all private health care providers. Diagnosis was accepted if typical endoscopy findings and at least 1 of 4 of the following criteria could be deduced from the charts: a) clinical symptoms like abdominal pain, diarrhea, bloody stools over a longer period of time b) histopathological findings in accordance with IBD c) findings typical for IBD in radiological imaging studies (barium enema, enteroclysis, computed tomography or magnetic resonance imaging) d) negative stool culture.
A further requirement for inclusion was that patients had to live in Styria (as apparent by the postal code of their home address) at the time of diagnosis. In case of phone or electronic registration a medical report with a diagnosis of IBD and basic investigations had to be available. In a few patients the diagnosis of a specific IBD (mostly indeterminate or ulcerative colitis) was made and later changed into another subgroup, primarily owing to histopathological or imaging findings. In these cases the first date of initial diagnosis was secured but the subgroup of IBD diagnosed last was accepted as diagnosis. In case of death or relocation data were deduced from existing documents if possible. All data had been anonymized and held in strict confidence. The study was approved by the Institutional Review Board (Ethical Committee) of the Medical University of Graz.
Statistical methods
All people living in the state of Styria between 1997 and 2007 were considered to be at risk. Postal codes were used to categorize urban and rural areas. Crude incidence rates were calculated for CD and UC separately by dividing the number of events by the population at risk. The direct method of standardization with the WHO World Standard Population (2000-2025) was used to estimate age-and sexstandardized incidence rates. The WHO world standard population instead of the national standard population was used to facilitate international comparative analysis. The 95% confidence intervals (95% CI) were estimated assuming a Poisson distribution. Poisson regression analysis was performed to assess changes in incidence rates over the time period and the different areas. All analyses were done using STATA 9 (StataCorp LP, Texas, USA).
Results
During the study period 1527 patients with an initial diagnosis of IBD comprising 813 with CD, 674 with UC and 40 with indeterminate colitis were identified. The average annual standardized incidence per 100,000 for IBD was 11.8 (95% 1-12. 3). Development of the incidence of CD and UC is shown in Fig. 3 . Incidence of CD and UC adjusted to decades and gender is shown in Table 3 . The number of new cases of IBD in children and adolescents is shown in Fig. 4. 
Incidence of Crohn's disease
The average annual standardized incidence per 100,000 was 6.7 (95% CI: 6.2-7.1), the crude incidence was 6.2 (95% CI: 5.8-6.6) ( Table 3 ). The average annual incidence increased significantly (p b 0.01) during the 11 year study period (Fig. 3) . The distribution of gender showed a slight predominance of female (54%) versus male patients (46%). With respect to the three study areas we noted a significantly higher incidence of CD in the urban area (8.8, 95% CI 7.8- 
Incidence of ulcerative colitis
The average annual standardized incidence per 100,000 was 4.8 (95% CI: 4.5-5.2), the crude incidence was 5.1 (95% CI: 4.8-5.6). The average annual incidence increased significantly (p b 0.01) during the study period (Fig. 3) . The gender distribution showed a slight predominance of male (54%) versus female patients (46%). Incidence of UC was significantly higher in the urban area (5.8, 95% CI 5.1-6.6) as compared to the rural areas observed in 18%, left sided colitis (E2) in 42% and extended colitis (E3) in 40% of patients.
Incidence of indeterminate colitis
Forty cases were diagnosed with indeterminate colitis. No change in the incidence was observed during the observation period (data not shown).
Age at initial diagnosis
The median age at diagnosis of CD was 29 years (range 3-87 years) (Fig. 5A) . The median age at diagnosis of UC was 39 years (range 3-94 years) (Fig. 5B) . The fraction of patients b 18 years of age at initial diagnosis was 11% for CD (89/813) and 5% (34/674) for UC.
Discussion
The current retrospective study is the first population-based investigation of IBD epidemiology in Austria. We aimed to determine the frequency of a primary diagnosis of IBD in a well defined region over an 11-year period from 1997 to 2007. We found an average annual incidence of 6.7 for CD and 4.8 for UC. The overall incidence of CD and UC increased over time. This latter finding is in contrast to some recent studies, where a plateau or even a decrease in the incidence of UC had been shown. 5, [11] [12] [13] [14] The numerous studies on the incidence of IBD performed in Europe and the most important overseas studies are summarized in Table 1 . Results vary extremely between 0.18 and 20.2/100,000/year for CD and between 0.97 and 24.8/ 100,000/year for UC. Aside from genetic and geographic differences possible explanations for the variability of incidence include different methods of case ascertainment, improved diagnostic tools, better documentation and increased awareness. With respect to prospective versus retrospective studies there is no uniform trend toward higher incidences in prospective studies. 4, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Most of the studies showing particularly high incidences were performed in northern European countries where on the basis of a more sophisticated public health care system all patients are registered. In addition, overall medical documentation is well established and available for epidemic research in Scandinavian countries. In Austria a quite diversified health care system is taking care of IBD patients. Although it is likely that the vast majority of IBD patients are seen in a hospital as outpatients or inpatients, some cases with mild or moderately active disease may have been treated exclusively by physicians in private practice without registration of diagnosis by the ICD system, or in any other way. We cannot exclude that such patients escaped detection in the present study, which would be in accordance with the rather low frequency of proctitis (18%) among the UC patients. CD is a much more complex condition, and it became usual to advise CD patients, even with mild activity, to consult a gastroenterologist in an IBD out-patient clinic for at least one time. Taken together, we are confident that the detection rate of CD in the present study was nearly complete. Nevertheless, our results must be interpreted with caution considering the retrospective design of the study.
Data on the incidence of IBD in adolescents and children are scarce. Results of the most important studies on the incidences of IBD in pediatric patients in both Europe and overseas are summarized in Table 4 . Similar to data on adults there is broad variation, ranging from 0.2 to 12/ 100,000/year for CD and from 0.7 to 10.6/100,000/year for UC. Studies comparing earlier and more recent time periods found a uniform trend towards an increase in the incidence of CD. [25] [26] [27] [28] [29] [30] [31] [32] There is no uniform trend for UC. Most studies described a plateau. 25, 26, 28, 30, 31 An epidemiologic study examining the incidence of UC in northern California between 1996 and 2006 revealed a significant increase from 1.8 to 4.9. 29 Overall, there seems to be a shift from UC to CD in the young age. Furthermore, numerous recent reports indicate an earlier onset of juvenile CD. 28, [33] [34] [35] During the present study period of 11 years, 130 patients (8.5%) below 18 years of age had received a first diagnosis of IBD. There Table 4 Major studies from Europe and overseas on the incidence of IBD in children and adolescents. were more CD patients (n = 89) than patients with UC (n = 34) (Fig. 4) , which is in general agreement with the literature (Table 4) . In Europe the mean age at initial diagnosis varies during the past 30 years between 32 and 44 years for CD and between 39 and 47 years for UC. 5, 16, 17, [36] [37] [38] The reported median age varies from 27 to 31 years for CD and from 31 to 38 years for UC. 18, 19, 33, 39, 40 Similar to previous reports the median age at diagnosis in the current study was 29 years for CD and 39 years for UC. For CD we found a peak of onset between 18 and 35 years of age. We did not observe a later second peak neither for CD nor for UC. The existence of a second peak of IBD onset remains controversial. For CD it has been described in some, 37, 41, 42 but not all studies. 2, 15, 17, 19, 33, 39, 43 For UC, the observation of a second peak of incidence is rare, and was only reported in two studies for subgroups of patients. 1, 44 The phenomenon of a second peak of IBD in elderly patients could be due, at least in part, to inadequate diagnostic criteria confounding IBD with other forms of colitis that are frequent in this age group, such as ischemic colitis, segmental colitis associated with diverticulitis, or colitis induced by NSAIDs.
In conclusion this large retrospective epidemiological study demonstrates a significantly increasing incidence over 11 years for both CD and UC. In 8.5% of patients IBD was diagnosed below the age of 18 years. We found a significantly higher incidence of IBD cases in the urban area than in rural areas.
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